What they were paid
Avalo Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $63,018 | $0 | $70,973 | — | $133,991 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Avalo Therapeutics, Inc. DEF 14A filed April 10, 2026, accession 0001534120-26-000022, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Avalo Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit
The rest of the Avalo Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Aaron Kantoff | Independent Director | $128,973 |
| Gilla Kaplan, Ph.D | Independent Director | $126,955 |
| Jonathan Goldman, M.D | Independent Director | $128,473 |
| Kevin Lind | Independent Director | $456,488 |
| Michael Heffernan | Chair of the Board | $509,578 |
| Rita Jain, M.D | Independent Director | $177,579 |
| Samantha Truex | Independent Director | $127,473 |
The full Avalo Therapeutics compensation record
free company briefThis page is one director within Avalo Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat